Nzyme
Enzyme
/‘ɛnzʌɪm/ noun. “Protein which acts as catalyst to accelerate the transformation of molecules in living organisms. It is not consumed during the reaction and can drive change over and over. In some cases, they allow a reaction that would otherwise take millions of years to occur in milliseconds.
In a nutshell, enzymes accelerate transformation…
…and so do we at Nzyme
About us
Nzyme is a private equity fund that supports exceptional teams to innovate and grow their entrepreneurial ventures. Just as enzymes do in living organisms, our goal is to accelerate transformation and to facilitate the integration of companies to create market-leading businesses.
Investment thesis
At Nzyme, we believe in the role of technology and business consolidation as catalysts for growth. Inspired by the critical function of enzymes in biology, Nzyme acts as a change agent in the business ecosystem, accelerating investment in talent, innovation, and growth. We unlock the constraints faced by small- and medium-sized enterprises, empowering them to consolidate leadership positions.
We invest in companies capable of becoming market leaders, targeting sectors where innovation and technology can create differential value and where sector consolidation provides the strength needed to achieve leadership. Ideally we look for:
Established businesses with positive EBITDA. Our investment range spans €10–20M in equity, with control.
Ambitious teams eager to work with a trusted partner to grow and create a leading company in their sector.
While we prioritize sectors such as business services (B2B) and software, we believe great potential can be found in any industry.
Why Nzyme?
A Visionary Team: Our team combines decades of experience in Private Equity, Venture Capital, and technology with proven ability to uncover and unlock hidden value in businesses.
Access to Global Resources: Our partnership with Oliver Wyman provides unmatched advantages, offering specialized insights and a global network of experts.
Commitment to Innovation: We see technology as the primary driver of value creation and work to integrate transformative solutions into traditional businesses.
Sustainable Impact: We aim not only for financial success but also to ensure our companies invest in a more sustainable and responsible future.
Team
The Nzyme team has decades of experience in Private Equity and Venture Capital, as well as leading transformation, digitization, and M&A processes. After more than a decade of working together, Nzyme is a cohesive and complementary team that knows how to understand, support, and complement the management teams we partner with.
If you believe Nzyme is the right place for your professional future, write to us at:
nzyme@kiboventures.com